G1 THERAPEUTICS INC. - COMMON STOCK

G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024

17 أبريل 2024 09:00:34 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

04 أبريل 2024 10:30:30 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 أبريل 2024 16:20:26 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 مارس 2024 16:20:33 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

28 فبراير 2024 06:30:52 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

27 فبراير 2024 08:30:01 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024

15 فبراير 2024 08:30:28 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee

12 فبراير 2024 16:05:18 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference

08 يناير 2024 06:45:52 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

03 يناير 2024 09:00:17 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 يناير 2024 16:51:10 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy

05 ديسمبر 2023 09:26:20 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 ديسمبر 2023 16:27:24 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium

29 نوفمبر 2023 20:37:45 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Provides Third Quarter 2023 Financial Results and Operational Highlights

01 نوفمبر 2023 06:30:53 بحسب Nasdaq GlobeNewswire

Real World Data Indicate That Trilaciclib Reduces Hospitalizations and Myelosuppressive Events and May Improve Survival in Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

27 أكتوبر 2023 07:00:54 بحسب Nasdaq GlobeNewswire

G1 Therapeutics’ COSELA® (trilaciclib) Recommended in Updated Small Cell Lung Cancer Guidelines from the American Society of Clinical Oncology (ASCO)

18 أكتوبر 2023 08:00:50 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 1, 2023

18 أكتوبر 2023 07:30:06 بحسب Nasdaq GlobeNewswire

G1 Therapeutics Announces Upcoming Presentations at the 2023 ASCO Quality Care Symposium

16 أكتوبر 2023 09:00:33 بحسب Nasdaq GlobeNewswire

G1 Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

05 سبتمبر 2023 11:00:29 بحسب Nasdaq GlobeNewswire